411 – 420 of 826
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment.
(
- Contribution to journal › Letter
-
Mark
Early Cellular Pathways of Mouse Natural Killer Cell Development.
(
- Contribution to journal › Scientific review
-
Mark
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
(
- Contribution to journal › Article
-
Mark
Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation
(
- Contribution to journal › Article
-
Mark
The dual regulator Sufu integrates Hedgehog and Wnt signals in the early Xenopus embryo
(
- Contribution to journal › Article
-
Mark
Gene expression profiling in MDS and AML: potential and future avenues.
(
- Contribution to journal › Article
-
Mark
A novel immunohistochemical sequential multi-labelling and erasing technique enables epitope characterization of bone marrow pericytes in primary myelofibrosis
2011) Danish Society for Pathological Anatomy and Clinical Cytology, Annual Meeting 2011 In APMIS 119. p.3-4(
- Contribution to journal › Published meeting abstract
-
Mark
A dose-dependent role for EBF1 in repressing non-B-cell-specific genes
(
- Contribution to journal › Article
-
Mark
TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Fibroblast growth factor 10 represses premature cell differentiation during establishment of the intestinal progenitor niche
(
- Contribution to journal › Article